PRENDERGAST FRANKLYN G 4
4 · Lantern Pharma Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
PRENDERGAST FRANKLYN G
Director
Transactions
- Award
Stock Option
2020-06-15+9,135→ 9,135 totalExercise: $15.00→ Common Stock (9,135 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted options to purchase 9,135 shares of the Issuer's common stock at the exercise price equal to the price per share sold in the Issuer's initial public offering ("IPO"). The options granted will vest in equal monthly increments over a 36 month period commencing upon the closing of the Issuer's IPO, which is the grant date of the options. Under the Amended and Restated 2018 Equity Incentive Plan, the options may not be exercised after the tenth anniversary of the grant date.